US Stock MarketDetailed Quotes

LNMG Linike Medical Group Ltd.

Watchlist
  • 0.220
  • 0.0000.00%
15min DelayTrading Apr 22 16:00 ET
764.35KMarket Cap8.15P/E (TTM)

Linike Medical Group Ltd. Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jul 31, 2014
(Q2)Apr 30, 2014
(Q1)Jan 31, 2014
(FY)Oct 31, 2013
(Q4)Oct 31, 2013
(Q3)Jul 31, 2013
(Q2)Apr 30, 2013
(Q1)Jan 31, 2013
(FY)Oct 31, 2012
(Q4)Oct 31, 2012
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
125.01%2.99K
-95.80%6.61K
-304.54%-32.61K
-11,817.15%-28.48K
-45,477.47%-165.9K
-115.73%-11.94K
473.63%157.42K
76.04%-8.06K
99.50%-239
96.31%-364
Net income from continuing operations
83.12%-10.43K
71.30%-22.83K
25.13%-38.17K
-651.28%-427.77K
-439.48%-235.47K
---61.76K
---79.56K
---50.98K
-35.18%-56.94K
---43.65K
Depreciation and amortization
----
----
----
--593
---4
--54
----
----
----
----
Change In working capital
-73.05%13.41K
-87.55%29.44K
-87.06%5.55K
603.16%398.69K
60.73%69.57K
108.36%49.77K
5,208.92%236.44K
835.02%42.92K
817.45%56.7K
124.26%43.28K
-Change in receivables
--0
----
----
----
----
--51
----
----
----
----
-Change in prepaid assets
105.53%2.85K
-100.02%-41
100.09%186
175.27%9.13K
501.14%48.65K
---51.65K
--225.54K
---213.41K
---12.13K
---12.13K
-Change in payables and accrued expense
97.72%-4.28K
163.92%29.48K
-97.91%5.37K
466.01%389.57K
459.64%310.1K
-1,447.91%-188.03K
314.83%11.17K
5,392.41%256.33K
970.90%68.83K
2,679.61%55.41K
Cash from discontinued investing activities
Operating cash flow
125.01%2.99K
-95.80%6.61K
-304.54%-32.61K
-11,817.15%-28.48K
-45,477.47%-165.9K
-115.73%-11.94K
473.63%157.42K
76.04%-8.06K
99.50%-239
96.31%-364
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
165.1K
0
-165.1K
0
0
0
Net other investing changes
----
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--165.1K
--0
---165.1K
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
0
0
0
711.05%16.22K
0
0
0
16.22K
-98.13%2K
116.53%1.99K
Net common stock issuance
----
----
----
----
----
----
----
----
-98.32%2K
--1.99K
Net other financing activities
----
----
----
--16.22K
--0
--0
--0
--16.22K
----
----
Cash from discontinued financing activities
Financing cash flow
--0
--0
--0
711.05%16.22K
--0
--0
--0
--16.22K
-98.13%2K
116.53%1.99K
Net cash flow
Beginning cash position
-93.34%208
-87.74%1.27K
30.21%2.59K
--1.99K
22,450.00%2.26K
-86.41%3.12K
-83.63%10.38K
-97.98%1.99K
--0
-99.99%10
Current changes in cash
125.01%2.99K
186.06%6.61K
-499.73%-32.61K
-796.25%-12.26K
-149.08%-798
-115.73%-11.94K
81.77%-7.68K
124.25%8.16K
-97.02%1.76K
107.42%1.63K
Effect of exchange rate changes
-127.50%-3.05K
-1,888.81%-7.67K
13,449.78%31.3K
5,616.00%12.86K
222.57%1.13K
3,263.43%11.07K
-75.57%429
115.09%231
117.81%225
106.78%350
End cash Position
-93.39%149
-93.34%208
-87.74%1.27K
30.21%2.59K
30.21%2.59K
22,450.00%2.26K
-86.41%3.12K
-83.63%10.38K
-97.98%1.99K
-97.98%1.99K
Free cash flow
125.01%2.99K
-95.80%6.61K
-304.54%-32.61K
-11,817.15%-28.48K
-45,477.47%-165.9K
-115.73%-11.94K
473.63%157.42K
76.04%-8.06K
99.50%-239
96.31%-364
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Jul 31, 2014(Q2)Apr 30, 2014(Q1)Jan 31, 2014(FY)Oct 31, 2013(Q4)Oct 31, 2013(Q3)Jul 31, 2013(Q2)Apr 30, 2013(Q1)Jan 31, 2013(FY)Oct 31, 2012(Q4)Oct 31, 2012
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 125.01%2.99K-95.80%6.61K-304.54%-32.61K-11,817.15%-28.48K-45,477.47%-165.9K-115.73%-11.94K473.63%157.42K76.04%-8.06K99.50%-23996.31%-364
Net income from continuing operations 83.12%-10.43K71.30%-22.83K25.13%-38.17K-651.28%-427.77K-439.48%-235.47K---61.76K---79.56K---50.98K-35.18%-56.94K---43.65K
Depreciation and amortization --------------593---4--54----------------
Change In working capital -73.05%13.41K-87.55%29.44K-87.06%5.55K603.16%398.69K60.73%69.57K108.36%49.77K5,208.92%236.44K835.02%42.92K817.45%56.7K124.26%43.28K
-Change in receivables --0------------------51----------------
-Change in prepaid assets 105.53%2.85K-100.02%-41100.09%186175.27%9.13K501.14%48.65K---51.65K--225.54K---213.41K---12.13K---12.13K
-Change in payables and accrued expense 97.72%-4.28K163.92%29.48K-97.91%5.37K466.01%389.57K459.64%310.1K-1,447.91%-188.03K314.83%11.17K5,392.41%256.33K970.90%68.83K2,679.61%55.41K
Cash from discontinued investing activities
Operating cash flow 125.01%2.99K-95.80%6.61K-304.54%-32.61K-11,817.15%-28.48K-45,477.47%-165.9K-115.73%-11.94K473.63%157.42K76.04%-8.06K99.50%-23996.31%-364
Investing cash flow
Cash flow from continuing investing activities 0000165.1K0-165.1K000
Net other investing changes ----------------------0----------------
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--165.1K--0---165.1K--0--0--0
Financing cash flow
Cash flow from continuing financing activities 000711.05%16.22K00016.22K-98.13%2K116.53%1.99K
Net common stock issuance ---------------------------------98.32%2K--1.99K
Net other financing activities --------------16.22K--0--0--0--16.22K--------
Cash from discontinued financing activities
Financing cash flow --0--0--0711.05%16.22K--0--0--0--16.22K-98.13%2K116.53%1.99K
Net cash flow
Beginning cash position -93.34%208-87.74%1.27K30.21%2.59K--1.99K22,450.00%2.26K-86.41%3.12K-83.63%10.38K-97.98%1.99K--0-99.99%10
Current changes in cash 125.01%2.99K186.06%6.61K-499.73%-32.61K-796.25%-12.26K-149.08%-798-115.73%-11.94K81.77%-7.68K124.25%8.16K-97.02%1.76K107.42%1.63K
Effect of exchange rate changes -127.50%-3.05K-1,888.81%-7.67K13,449.78%31.3K5,616.00%12.86K222.57%1.13K3,263.43%11.07K-75.57%429115.09%231117.81%225106.78%350
End cash Position -93.39%149-93.34%208-87.74%1.27K30.21%2.59K30.21%2.59K22,450.00%2.26K-86.41%3.12K-83.63%10.38K-97.98%1.99K-97.98%1.99K
Free cash flow 125.01%2.99K-95.80%6.61K-304.54%-32.61K-11,817.15%-28.48K-45,477.47%-165.9K-115.73%-11.94K473.63%157.42K76.04%-8.06K99.50%-23996.31%-364
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg